MARKET

SENS

SENS

SENSEONICS
AMEX

Real-time Quotes | Nasdaq Last Sale

3.190
-0.100
-3.04%
Pre Market: 2.960 -0.23 -7.21% 08:15 03/04 EST
OPEN
3.220
PREV CLOSE
3.290
HIGH
3.520
LOW
3.130
VOLUME
354.12K
TURNOVER
--
52 WEEK HIGH
5.56
52 WEEK LOW
0.3497
MARKET CAP
1.07B
P/E (TTM)
-6.1690
1D
5D
1M
3M
1Y
5Y
Senseonics Holdings, Inc. Common Stock's Earnings: A Preview
On Thursday, March 04, Senseonics Holdings, Inc. Common Stock (AMEX:SENS) will release its latest earnings report. Check out Benzinga's preview to understand the implications. What Are Earnings, Net Income, And Earnings Per Share? Earnings and especially e...
Benzinga · 21h ago
Global Implantable Remote Patient Monitoring Device Market Share, Trends (2021-2027): Profusa Inc., Abbott, Qura Inc. and Medtronic
Mar 03, 2021 (WiredRelease via Comtex) -- “Implantable Remote Patient Monitoring Device Market by Type Implantable Cardiovascular Monitoring Device,...
marketresearch.biz · 1d ago
Senseonics to Participate in the H.C. Wainwright Global Life Sciences Conference
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to particip...
Business Wire · 1d ago
As Rocket Mortgage pops, here are some other top short squeeze candidates
Several large stocks have high short interest levels even after the GameStop saga.
CNBC.com · 1d ago
Thinking about buying stock in Cerecor, Surface Oncology, SINTX Technologies, Clearpoint Neuro, or Senseonics Holdings?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CERC, SURF, SINT, CLPT, and SENS.
PR Newswire - PRF · 1d ago
Sensionics Awarded U.S. Patent 10,932,703 'Integrated optical filter system with low sensitivity to high angle of incidence light for an analyte sensor'
View Patent Here
Benzinga · 1d ago
Global Smart Continuous Glucose Monitoring System Market Research Report 2020-2026
Feb 26, 2021 (Heraldkeepers) -- The research report has incorporated the analysis of different factors that augment the market's growth. It constitutes...
Heraldkeepers · 5d ago
Global Implantable Remote Patient Monitoring Device Market Size By End User, By Region 2021 | Overview, Growth, Economics, Demand And Forecast Research Report To 2026
Feb 24, 2021 (The Expresswire) -- The report provides revenue of the global Implantable Remote Patient Monitoring Device Marketfor the period 2016 and 2026,...
The Express Wire · 02/24 05:28
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SENS. Analyze the recent business situations of SENSEONICS through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SENS stock price target is 0.9250 with a high estimate of 1.000 and a low estimate of 0.7000.
EPS
Institutional Holdings
Institutions: 117
Institutional Holdings: 93.52M
% Owned: 27.82%
Shares Outstanding: 336.19M
TypeInstitutionsShares
Increased
49
4.74M
New
13
3.28M
Decreased
18
5.37M
Sold Out
21
1.58M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-3.96%
Pharmaceuticals & Medical Research
-1.89%
Key Executives
Chairman/Independent Director
Stephen DeFalco
President/Chief Executive Officer/Director
Timothy Goodnow
Chief Financial Officer/Treasurer/Secretary
Nick Tressler
Chief Operating Officer
Mukul Jain
Vice President/General Manager
Mirasol Panlilio
Other/Director
Francine Kaufman
Director
Anthony Raab
Director
Robert Schumm
Independent Director
Steven Edelman
Independent Director
Edward Fiorentino
Independent Director
Peter Klein
Independent Director
Douglas Prince
Independent Director
Douglas Roeder
No Data
About SENS
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.

Webull offers kinds of Senseonics Holdings Inc stock information, including AMEX:SENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SENS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SENS stock methods without spending real money on the virtual paper trading platform.